Related Experiment Video
Updated: Sep 18, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
CRISPR-Cas9 mediated RALA knockout and reconstitution: insights into the detection and role of RALA S194
Mayuresh Vishwas Konde1, Siddhi Inchanalkar1, Tushar Manik Sherkhane1
1IISER Pune: Indian Institute of Science Education Research Pune, India.
Abstract:
Downstream of oncogenic RAS, RALA is critical for cancer tumorigenesis, possibly regulated by phosphorylation of its Serine194 residue. We made CRISPR-Cas9 RALA knockout (RALA KO) in three RAS-dependent and two RAS-independent cancer cells. Detection of RALA S194 phosphorylation using the commercial anti-phospho-RALA antibody lacks specificity in all three RAS-dependent cancers. siRNA knockdown of RALA and AURKA inhibition by MLN8237 (VMLN) also did not affect pS194RALA detection in these cancers. RALA KO MiaPaCa2 (RAS-dependent) and MCF7 (RAS-independent) cells, stably reconstituted with WT-RALA and S194A-RALA mutants, showed no effect on RALA activation. Tumor growth was, however, restored partly by WT-RALA, but not S194A-RALA mutant. Thus, RALA S194 phosphorylation is needed for tumor formation, not affecting its activation, but possibly through its localization.
Insights
RAS-driven cancer relies on RALA, but its Serine194 phosphorylation is not essential for activation. This phosphorylation is crucial for tumor formation, potentially by influencing RALA localization.
Area of Science:
- Molecular Oncology
- Cancer Biology
- Signal Transduction
Background:
- RAS oncogenes drive cancer by activating downstream effectors like RALA.
- RALA's role in tumorigenesis is potentially regulated by phosphorylation at Serine194.
- Understanding RALA phosphorylation is critical for targeting RAS-dependent cancers.
Purpose of the Study:
- To investigate the role of RALA Serine194 phosphorylation in cancer.
- To determine if RALA S194 phosphorylation affects RALA activation or tumor formation.
- To assess the specificity of anti-phospho-RALA antibodies in cancer models.
Main Methods:
- CRISPR-Cas9 RALA knockout (RALA KO) in RAS-dependent and independent cancer cells.
- Reconstitution of RALA KO cells with wild-type (WT) RALA and S194A-RALA mutants.
- Assessment of RALA activation, pS194RALA detection, and tumor growth restoration.
Main Results:
- Commercial anti-phospho-RALA antibody lacked specificity in RAS-dependent cancers.
- RALA S194 phosphorylation did not affect RALA activation in reconstituted cells.
- WT-RALA restored tumor growth in RALA KO cells, but the S194A-RALA mutant did not.
Conclusions:
- RALA Serine194 phosphorylation is essential for tumor formation, not RALA activation.
- The S194 residue's role in tumor growth may be linked to RALA localization.
- This finding offers new insights into RALA's function in oncogenesis.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Abnormal Proliferation
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...